16
Jan
An integrated microfluidic chip for isolation, culture and drug susceptibility testing of cancer cells
Abstract "Cancer patients with advanced disease are characterized by intrinsic challenges in predicting drug response patterns, often leading to ineffective treatment. Current clinical practice for treatment decision-making is commonly based on primary or secondary tumour biopsies, yet when disease progression accelerates, tissue biopsies are not performed...
17:32 /
Latest Research
